Regeneron secures expanded FDA nod for Evkeeza to include young children
The FDA approval extends Evkeeza’s indication to include children aged five to 11 years with homozygous familial hypercholesterolemia…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Mar 23
The FDA approval extends Evkeeza’s indication to include children aged five to 11 years with homozygous familial hypercholesterolemia…
23 Mar 23
The approval was based on clinical data from the global ReSTORE phase 3 trial and is also backed…
21 Mar 23
"There was such incredible fan reaction following our first partnership with Minecraft, we had to bring it back…
21 Mar 23
As the first-ever compostable tea wrapper to be certified by the BPI, the packaging meets stringent standards for…
21 Mar 23
"We hope to inspire moments of everyday happiness with our newest innovation, DOVE Milk Chocolate Molten Lava Caramel…
21 Mar 23
"Easter has always been a special holiday for me, and now I love passing on the traditions I…
21 Mar 23
Herbalife Nutrition Foundation (HNF) announced today it reached its goal of raising $1.5 million at its annual Gala…
21 Mar 23
The Earth Fund is supporting this effort with $19.1 million in new grants to CDP and the GHG Protocol
21 Mar 23
The collaboration aims to develop and market OncoC4’s monoclonal antibody candidate, ONC-392, as a standalone, or combination therapy…
21 Mar 23
Designated as GS-6791, NX‑0479 is a bivalent degrader which is the first development candidate resulting from the previously…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates